Crossmark

Utilization of standardized preimplantation genetic testing for aneuploidy (PGT-A) via artificial intelligence (AI) technology is correlated with improved pregnancy outcomes in single thawed euploid embryo transfer (STEET) cycles

Crossref DOI link: https://doi.org/10.1007/s10815-022-02695-7

Published Online: 2023-01-07

Published Print: 2023-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Buldo-Licciardi, Julia https://orcid.org/0000-0001-8222-9439
Large, Michael J.

McCulloh, David H.

McCaffrey, Caroline

Grifo, James A.
License Information

Text and Data Mining valid from 2023-01-07

Version of Record valid from 2023-01-07
More Information

Article History

Received: 2 June 2022

Accepted: 13 December 2022

First Online: 7 January 2023

Declarations

:

: Julia Buldo-Licciardi, M.D.—none.Michael J. Large, Ph.D.—author on published patent applications related to technology described. Own COO stock, the parent company responsible for genetic testing described. Employed by the company responsible for the genetic testing described.David H. McCulloh, Ph.D.—none.Caroline McCaffrey, Ph.D.—none.James A. Grifo, M.D., Ph.D.—stock or stock options: Prelude Fertility Holdings LLC.

Document is current

Any future updates will be listed below